GUBBA PHARMA IN E NEWS

Read More

Regulator waives off clinical trials, clears Sanofi TB drug

November 6, 2019 Gubba Pharma In E News

India’s drug regulator has approved (India)’s new anti-tuberculosis drug rifapentine , waiving local clinical trials in a move to bolster efforts to prevent latent infections...

Continue Reading

Read More

J&J unveils next-gen monofocal intraocular lens in India

November 6, 2019 Gubba Pharma In E News

In an endeavour recognizing the need to provide solutions to post-operative cataract patients to enhance vision, Johnson & Johnson Vision, a global leader in eye...

Continue Reading

Read More

Drug Manufacturing: Implications of the U.S. – E.U. Mutual Recognition Agreement

November 6, 2019 Gubba Pharma In E News

the United States and European Union finalized a Mutual Recognition Agreement (MRA) for drug manufacturing inspections. Both parties have now fully implemented the MRA for...

Continue Reading

Read More

Prospective Need For: Vegetable Seed Storage

October 31, 2019 ., Gubba Pharma In E News

India is the second-largest producer of fresh fruits and vegetables. Unfortunately, due to the lack of knowledge and facility, the country ends up wasting almost...

Continue Reading

Read More

INTENTIONS AND OMISSIONS IN HEALTH CARE

October 30, 2019 Gubba Pharma In E News

For being born as Human being all through my professional years, I relished the journey of my life from where I was once to be...

Continue Reading

Read More

GSK’s SAM technology could revolutionise vaccines

October 30, 2019 Gubba Pharma In E News

At GSK, we work on vaccines aiming to help combat devastating infectious diseases like malaria, tuberculosis, HSV, RSV and COPD. Jeff Ulmer, Head Preclinical R&D...

Continue Reading

Read More

Biocon’s biologics portfolio comes into its own

October 30, 2019 Gubba Pharma In E News

Five years ago, Biocon’s biologics business largely consisted of insulin clones and was worth about ₹400 crore. At the time, Biocon was valued at just...

Continue Reading

Read More

Roche’s Tecentriq scores a first-in-class double win in new liver cancer patients

October 24, 2019 Gubba Pharma In E News

Roche is out with phase 3 Tecentriq results in liver cancer, and it’s out in full force. The immuno-oncology med, in combination with fellow Roche...

Continue Reading

Read More

From the Neuland Reading Room

October 24, 2019 Gubba Pharma In E News

1989 to Present: PharmTech Highlights 30 Years of Bio/Pharma PharmTech tackles 30 years of the pharma & biopharmaceutical industries – from the launch of ICH,...

Continue Reading